Home > Healthcare > Medical Devices > Therapeutic Devices > Automated External Defibrillator Market

Automated External Defibrillator Market - By Product Type (Semi-automated External Defibrillator, Fully-automated External Defibrillator), By Patient (Adult, Pediatric), By End-use (Hospitals, Prehospital Care, Homecare) – Global Forecast, 2024 – 2032

  • Report ID: GMI8509
  • Published Date: Mar 2024
  • Report Format: PDF

Automated External Defibrillator Market Size

Automated External Defibrillator Market size was valued at around USD 1.3 billion in 2023 and is expected to reach around USD 2.4 billion by 2032 at a CAGR of 7.1% during the forecast period. The market is expected to experience growth driven by the surging expenditure on the R&D by private sector coupled with the increasing advancements in product technology.

Automated External Defibrillator Market

Continuous technological innovation results in AEDs featuring intuitive interfaces, incorporating visual and audio prompts for simplified operation. For instance, the Philips HeartStart FR3 AED boasts a responsive touchscreen and clear voice instructions, facilitating swift and accurate usage even in high-stress situations. Modern AEDs leverage smart monitoring and connectivity, enabling real-time tracking of device status, battery life, and operational readiness. The ZOLL AED 3, equipped with WiFi and cellular capabilities, allows remote monitoring and sends alerts for necessary maintenance, ensuring optimal performance.

Furthermore, increased private sector investment in research and development further accelerates technological breakthroughs in AEDs. Robust R&D initiatives foster innovation, driving the creation of more advanced and reliable AED models that can contribute to improved survival rates in sudden cardiac arrest incidents, driving the market's growth.

An Automated External Defibrillator (AED) is a portable, electronic device designed to analyze the heart's rhythm and deliver an electric shock to restore a normal heartbeat in the event of sudden cardiac arrest. These devices play a crucial role in providing timely intervention, as they can quickly assess the heart's rhythm, determine the need for defibrillation, and deliver a controlled electric shock to the heart to correct irregular rhythms.


Automated External Defibrillator Market Trends

The escalating prevalence of cardiac diseases is a key driver fuelling the growth of the automated external defibrillators (AEDs) industry, compelling organizations, and communities to prioritize the accessibility and deployment of these life-saving devices.

  • The escalating incidence of cardiovascular diseases, including sudden cardiac arrest (SCA), underscores the critical need for effective and rapid intervention. For instance, according to the Centers for Disease Prevention and Control (CDC) statistics, in 2023, more than 356,000 people have an out-of-hospital cardiac arrest in the U.S. every year.
  • SCA is a leading cause of mortality globally, emphasizing the importance of AEDs in delivering prompt defibrillation to restore normal heart rhythm. The critical role of AEDs in addressing these specific cardiac conditions positions them as essential tools in emergency response strategies, contributing significantly to the expanding landscape of automated external defibrillator adoption.
  • Moreover, given the heightened risk of cardiovascular events in certain environments such as workplaces, public spaces, and community settings, the installation of cardiovascular devices becomes a proactive strategy. Placing AEDs in these high-risk areas ensures rapid access during emergencies, contributing to the overall safety and well-being of individuals at risk of cardiac events, and contributing to the market growth positively.

Automated External Defibrillator Market Analysis

Automated External Defibrillator Market, By Product Type, 2021 – 2032  (USD Billion)

The market by product type is categorized into semi-automated external defibrillators and fully-automated external defibrillators. The semi-automated external defibrillator segment dominates the market with a revenue of around USD 741 million in 2023.

  • The dominant market share of semi-automated external defibrillators (SAED) can be attributed to their intuitive interfaces, real-time guidance features, and suitability for diverse settings. These devices, designed for user-friendly operation and guided defibrillation processes, have gained prominence due to their effectiveness in enabling both trained and non-professional responders to deliver rapid and accurate defibrillation during emergency situations.  

  • Moreover, the semi-automated features of SAEDs provide a level of oversight by allowing healthcare professionals to assess the patient's condition continually. This adaptability ensures that medical personnel can intervene or modify the defibrillation process as needed, fostering a more personalized and responsive approach to patient care. Due to such advantages, the segment is anticipated to grow over the forecast period.

The automated external defibrillator market by patient is categorized into adult and pediatric. The adult segment dominates the market with a revenue of around USD 1.1 billion in 2023.

  • A major factor contributing to the dominance of automated external defibrillators (AEDs) for adult use is the notable increase in the geriatric population. The aging demographic profile worldwide has substantial implications for the prevalence and management of cardiac emergencies, thus shaping the landscape of AED usage.
  • For instance, according to the Centers for Disease Control and Prevention data, in 2019, 10.9% of adults aged 45 years and older reported having coronary heart disease (CHD). Similarly, 7.1% of adults aged 45 to 64 years reported having CHD compared with 17.0% of adults aged 65 years and older. The geriatric population experiences a higher incidence of cardiac events, necessitating the availability of these cardiac rhythm management devices tailored to the specific physiological characteristics and heart rhythms observed in adults.
  • Moreover, senior living facilities, including nursing homes and assisted living communities, strategically deploy adult AEDs due to the concentration of elderly residents. The presence of these devices addresses the immediate needs of seniors in the event of a cardiac emergency, aligning with the proactive healthcare approach in such settings, driving segment expansion.
Automated External Defibrillator Market, By End-use (2023)

The automated external defibrillator market by end-use is categorized into hospitals, prehospital care, homecare, and other end-users. The prehospital care segment held a significant market share in 2023 and is expected to register a CAGR of 7.5% over the analysis period.

  • Cardiac emergencies, particularly instances of sudden cardiac arrest (SCA), demand immediate attention. Prehospital care, often provided by emergency medical services (EMS) and first responders, aims to deliver timely interventions, making AEDs a crucial component in prehospital cardiac care.
  • Moreover, AEDs are strategically placed in ambulances and other first responder vehicles, ensuring that these life-saving devices are readily available at the scene of an emergency. The mobility of prehospital care units enables rapid deployment to various locations, addressing cardiac emergencies wherever they occur, hence, driving the growth of the market.
North America Automated External Defibrillator Market, 2020 – 2032 (USD Million)

North America automated external defibrillator market accounted for USD 474.3 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

  • The dominant share of North America in the global automated external defibrillators market is primarily attributed to several factors such as the presence of major industry players, surging prevalence of chronic heart diseases, supportive government initiatives, facilitative reimbursement scenario, and the presence of well-developed healthcare infrastructure. Additionally, the surge in private research funding for research and development of novel devices is propelling the regional market growth.
  • Moreover, North America has an extensive patient population and well-established healthcare systems, including advanced cardiac care facilities, North America offers ready access to diagnosis, management, and treatment options for cardiac patients. The region is a hub for clinical research and trials in the field, further propelling the innovation of AED devices. Furthermore, stringent regulatory oversight and the availability of health insurance coverage ensure that AED devices adhere to high safety and efficacy standards while remaining accessible to patients, further fueling demand.

Automated External Defibrillator Market Share

The automated external defibrillator industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for automated external defibrillator manufacturers.

Automated External Defibrillator Market Companies

Some of the eminent market participants operating in the automated external defibrillator industry include:

  • Amiitalia
  • Asahi Kasei Group
  • BPL Medical Technologies Pvt Ltd.
  • CU Medical Germany GmbH
  • Meditech Group
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • Schiller AG
  • Stryker Corporation

Automated External Defibrillator Industry News:

  • In June 2020, Royal Philips received premarket approval (PMA) for its HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs) from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA). The HeartStart FR3 is a professional-grade AED for medical personnel and first-responders. This approval helped the company to gain a competitive edge over its peers in the industry.
  • In September 2019, Mindray launched the BeneHeart C Series automated external defibrillator (AED) with smarter operations and faster shock delivery to achieve better resuscitation outcomes for sudden cardiac arrest (SCA). With both fully and semi-automatic versions, this product was launched in Europe and other selected countries. This product launch helped the company to enhance its customer base and expand to new geographies.

The automated external defibrillator market research report includes an in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Semi-automated external defibrillator
  • Fully-automated external defibrillator

Market, By Patient

  • Adult
  • Pediatric

Market, By End-use

  • Hospitals
  • Prehospital care
  • Homecare
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global automated external defibrillator market was valued at around USD 1.3 billion in 2023 and is expected to reach around USD 2.4 billion by 2032 at a CAGR of 7.1%, driven by the surging expenditure on the R&D by private sector coupled with the increasing advancements in product technology.

The prehospital care segment held a significant market share in 2023 and is expected to register a CAGR of 7.5% through 2032, owing to the demand for immediate attention required during cardiac emergencies, particularly instances of sudden cardiac arrest (SCA).

North America automated external defibrillator market accounted for USD 474.3 million in 2023 and will continue to grow through 2032, attributed to the presence of major industry players in the region, surging prevalence of chronic heart diseases, and supportive government initiatives.

Amiitalia, Asahi Kasei Group, BPL Medical Technologies Pvt Ltd., CU Medical Germany GmbH, Meditech Group, Mindray Medical International Limited, Nihon Kohden Corporation, Koninklijke Philips N.V., Schiller AG, and Stryker Corporation.

Automated External Defibrillator Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 251
  • Countries covered: 22
  • Pages: 165
 Download Free Sample